Holland JP - Search Results

1

Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Holland JP, Lewis JS, Dehdashti F. Holland JP, et al. Q J Nucl Med Mol Imaging. 2009 Apr;53(2):193-200. Q J Nucl Med Mol Imaging. 2009. PMID: 19293767 Free PMC article. Review.

2

Cerenkov luminescence imaging of medical isotopes.

Ruggiero A, Holland JP, Lewis JS, Grimm J. Ruggiero A, et al. Among authors: holland jp. J Nucl Med. 2010 Jul;51(7):1123-30. doi: 10.2967/jnumed.110.076521. Epub 2010 Jun 16. J Nucl Med. 2010. PMID: 20554722 Free PMC article.

3

Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions.

Holland JP, Normand G, Ruggiero A, Lewis JS, Grimm J. Holland JP, et al. Mol Imaging. 2011 Jun;10(3):177-86, 1-3. Mol Imaging. 2011. PMID: 21496448 Free PMC article.

4

Unconventional nuclides for radiopharmaceuticals.

Holland JP, Williamson MJ, Lewis JS. Holland JP, et al. Mol Imaging. 2010 Feb;9(1):1-20. Mol Imaging. 2010. PMID: 20128994 Free PMC article. Review.

5

Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Holland JP, Ferdani R, Anderson CJ, Lewis JS. Holland JP, et al. PET Clin. 2009 Jan;4(1):49-67. doi: 10.1016/j.cpet.2009.04.013. PET Clin. 2009. PMID: 27156895 Free PMC article.

6

Standardized methods for the production of high specific-activity zirconium-89.

Holland JP, Sheh Y, Lewis JS. Holland JP, et al. Nucl Med Biol. 2009 Oct;36(7):729-39. doi: 10.1016/j.nucmedbio.2009.05.007. Epub 2009 Jul 29. Nucl Med Biol. 2009. PMID: 19720285 Free PMC article.

7

89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Holland JP, Divilov V, Bander NH, Smith-Jones PM, Larson SM, Lewis JS. Holland JP, et al. J Nucl Med. 2010 Aug;51(8):1293-300. doi: 10.2967/jnumed.110.076174. Epub 2010 Jul 21. J Nucl Med. 2010. PMID: 20660376 Free PMC article.

8

Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.

Ruggiero A, Villa CH, Holland JP, Sprinkle SR, May C, Lewis JS, Scheinberg DA, McDevitt MR. Ruggiero A, et al. Among authors: holland jp. Int J Nanomedicine. 2010 Oct 5;5:783-802. doi: 10.2147/IJN.S13300. Int J Nanomedicine. 2010. PMID: 21042424 Free PMC article.

9

Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system.

Heneweer C, Holland JP, Divilov V, Carlin S, Lewis JS. Heneweer C, et al. Among authors: holland jp. J Nucl Med. 2011 Apr;52(4):625-633. doi: 10.2967/jnumed.110.083998. Epub 2011 Mar 18. J Nucl Med. 2011. PMID: 21421727 Free PMC article.

10

Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET.

Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova A, Bander NH, Lewis JS, Grimm J. Ruggiero A, et al. Among authors: holland jp. J Nucl Med. 2011 Oct;52(10):1608-15. doi: 10.2967/jnumed.111.092098. Epub 2011 Sep 9. J Nucl Med. 2011. PMID: 21908391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters